Distinguished in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Distinguished in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Pratt Medical Group Inc
800 Washigton St, 
Boston, MA 

Overview

Raymond Comenzo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Comenzo is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Cardiac Amyloidosis, Bone Marrow Transplant, and Tissue Biopsy. Dr. Comenzo is currently accepting new patients.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).

Specialties
Hematology Oncology
Hematology
Licenses
Internal Medicine in NY
Hospital Affiliations
Tufts Medical Center
Lowell General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

PRATT MEDICAL GROUP INC
800 Washigton St, Boston, MA 02111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)
View 7 Less Clinical Trials
Similar Doctors
Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Oncology | Hematology
Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Oncology | Hematology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (2.4 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Irene Ghobrial is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Ghobrial is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Ghobrial is currently accepting new patients.

Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology Oncology | Hematology | Oncology
Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology Oncology | Hematology | Oncology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (2.4 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Elizabeth O'donnell is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. O'donnell is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Orchiectomy, and Bone Marrow Aspiration. Dr. O'donnell is currently accepting new patients.

Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology Oncology | Hematology | Oncology
Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology Oncology | Hematology | Oncology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (2.4 miles away)
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Jorge Castillo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Castillo is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Waldenstrom Macroglobulinemia, B-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Castillo is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Comenzo's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile